FDA Clearance Tracker · P010019
FOCUS NIGHT AND DAY (LOTRAFILCON A) SOFT CONTACT LENSES
Last checked: Nov 20, 2026Latest source record: Oct 11, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Oct 11, 2001
Approved
Time to decision
204 days
Received Mar 21, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P010019
- Device name
- FOCUS NIGHT AND DAY (LOTRAFILCON A) SOFT CONTACT LENSES
- Applicant
- Alcon Laboratories, Inc.
- Applicant location
- Fort Worth, TX
- Received
- Mar 21, 2001
- Decided
- Oct 11, 2001
- Decision
- Approved
- Supplements
- 83 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Lenses, soft contact, extended wear (LPM)
- Device class
- Class III
- Regulation
- 21 CFR 886.5925
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE FOCUS NIGHT AND DAY (LOTRAFILCON A) SOFT CONTACT LENSES FOR EXTENDED WEAR. THE DEVICE WILL BE MARKETED WITH THE FOLLOWING TRADE NAMES AND INDICATIONS: FOCUS NIGHT AND DAY (LOTRAFILCON A) SOFT CONTACT LENSES ARE INDICATED FOR THE OPTICAL CORRECTION OF REFRACTIVE AMETROPIA (MYOPIA AND HYPEROPIA) IN PHAKIC OR APHAKIC PERSONS WITH NON-DISEASED EYES AND WITH UP TO APPROXIMATELY 1.50 DIOPTERS OF ASTIGMATISM. FOCUS NIGHT AND DAY TORIC (LOTRAFILCON A) SOFT CONTACT LENSES ARE INDICATED FOR THE OPTICAL CORRECTION OF REFRACTIVE AMETROPIA (MYOPIA AND HYPEROPIA IN PHAKIC OR APHAKIC PERSONS WITH NON-DISEASED EYES WITH 6.00 DIOPTERS (D) OR LESS OF ASTIGMATISM. FOCUS NIGHT AND DAY PROGRESSIVES (LOTRAFILCON A) SOFT CONTACT LENSES ARE INDICATED FOR THE OPTICAL CORRECTION OF REFRACTIVE AMETROPIA (MYOPIA AND HYPEROPIA) AND/OR PRESBYOPIA IN PHAKIC OR APHAKIC PERSONS WITH NON-DISEASED EYES WHO MAY REQUIRE A READING ADDITION OF +3.00 DIOPTERS (D) OR LESS AND WHO MAY HAVE UP TO APPROXIMATELY 1.50 DIOPTERS OF ASTIGMATISM. THE LENSES MAY BE PRESCRIBED FOR EXTENDED WEAR FOR UP TO 30 NIGHTS OF CONTINUOUS WEAR, WITH REMOVAL FOR DISPOSAL, OR CLEANING AND DISINFECTION PRIOR TO REINSERTION, AS RECOMMENDED BY THE EYE CARE PROFESSIONAL.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPM. The earliest in FDA's data is N16895, decided Mar 18, 1971.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Alcon Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K252682 · Decided Sep 24, 2025 · 30 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K243896 · Decided Apr 28, 2025 · 131 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.